Skip to content

Robert Hepler

  • MS
  • Principal Scientist
  • Janssen Research and Development Spring House
  • 13h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 789CitationsNumber of citations received by Robert's publications. Updated daily.

Research interests

analytical biochemistryprotein sceincevaccinesbiochemistry

Co-authors (135)

  • karnika joshi

Publications (5)

  • Efficacy of a capsule conjugate vaccine against inhalational anthrax in rabbits and monkeys

    • Chabot D
    • Joyce J
    • Caulfield M
    • et al.
    N/AReaders
    13Citations
    Get full text
  • Small molecule mimetics of an HIV-1 gp41 fusion intermediate as vaccine leads

    • Caulfield M
    • Dudkin V
    • Ottinger E
    • et al.
    N/AReaders
    2Citations
    Get full text
  • Vaccination with peptide mimetics of the gp41 prehairpin fusion intermediate yields neutralizing antisera against HIV-1 isolates

    • Bianchi E
    • Joyce J
    • Miller M
    • et al.
    N/AReaders
    37Citations
    Get full text
  • A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection

    • Hepler R
    • Kelly R
    • McNeely T
    • et al.
    N/AReaders
    18Citations
    Get full text
  • Isolation, structural characterization, and immunological evaluation of a high-molecular-weight exopolysaccharide from Staphylococcus aureus

    • Joyce J
    • Abeygunawardana C
    • Xu Q
    • et al.
    N/AReaders
    76Citations
    Get full text

Professional experience

Principal Scientist

Janssen Research and Development Spring House

November 2017 - Present

Senior Research Scientist

Johnson & Johnson

December 2013 - Present

Principal Scientist

Merck Research Labs

December 1990 - December 2013(23 years)